Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,397
Closed -$751K – 175
2026
Q1
$751K Hold
3,397
– – 0.32% 76
2025
Q4
$861K Hold
3,397
– – 0.38% 67
2025
Q3
$841K Hold
3,397
– – 0.38% 71
2025
Q2
$816K Hold
3,397
– – 0.39% 80
2025
Q1
$770K Hold
3,397
– – 0.41% 77
2024
Q4
$698K Hold
3,397
– – 0.36% 86
2024
Q3
$824K Hold
3,397
– – 0.4% 78
2024
Q2
$746K Hold
3,397
– – 0.37% 87
2024
Q1
$764K Hold
3,397
– – 0.37% 87
2023
Q4
$747K Hold
3,397
– – 0.4% 87
2023
Q3
$745K Hold
3,397
– – 0.53% 67
2023
Q2
$764K Hold
3,397
– – 0.47% 72
2023
Q1
$650K Buy
+3,397
New +$657K 0.42% 85

Other funds holding STE

Matisse Capital's STE Position: Q2 2026 in Review

Matisse Capital sold out of Steris (STE) in Q2 2026, closing a stake of 3,397 shares — an estimated $751K sold.

Matisse Capital first reported a position in STE in Q1 2023 and held it in 13 quarters. The position peaked at $861K in Q4 2025. 839 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Matisse Capital reported no remaining Steris position as of Q2 2026 after selling out during the quarter.
  • Matisse Capital sold 3,397 Steris shares in Q2 2026, an estimated $751K.
  • Matisse Capital first reported a position in Steris in Q1 2023 and held it in 13 quarters.
  • Matisse Capital's Steris position peaked at $861K in Q4 2025.
  • 839 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Matisse Capital's 13F filing for Q2 2026, filed 12 Aug 2026.